Medical Affairs Plans: From Strategic Planning to Measuring Impact — Episode 3
Listeners will understand how the Medical Affairs strategic planning process can drive decision making throughout the year.
Field Medical Stakeholders: Partnering for Today and Tomorrow – Episode 2 Global Product Strategy
Participants will learn the functions and activities of key internal partners and will identify potential areas for compliant collaboration with these partners.
Patient as Priority: Designing and Refining Internal Medical Affairs Training to Support Patient Outcomes
In partnership with experts from Open Health and Janssen EMEA, this episode of the MAPS podcast series Elevate details how to position patients as priority in designing and refining internal training.
History of Real-World Evidence Prior to the 21st Century Cures Act
Medical Affairs thought leaders discuss the Pre-21st Century Cures Act uses of Real World Evidence (RWE) in regulatory decision-making.
Medical Affairs Plans: From Strategic Planning to Measuring Impact – Episode 2
The Series Podcast Objectives are:
Podcast objectives include understanding how the medical affairs strategic planning process can drive decision making throughout the year
Field Medical Stakeholders: Partnering for Today and Tomorrow (Episode 1 — Global Communications)
Medical Affairs thought leaders discuss the function, activities and opportunities for compliant collaboration with key internal partners.
Joseph Eid: From Childhood in Civil War Lebanon to Medical Affairs Leader
Nothing could stand between Joseph Eid and his dream of becoming a doctor—not even gunfire.
The Application of Real-World Evidence in Regulatory Decision Making
Cerise James, MD, moderates this podcast in which Neil Belson, JD, discusses Real World Evidence and its impact to the biopharmaceutical industry.
Contemporary Applications of Real-World Evidence in Regulatory Decision Making: A Case Series Review
Real-World Evidence can show safety and effectiveness per FDA’s “totality of evidence approach” for evaluating regulatory submissions.